×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MAIA – maia biotechnology, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MAIA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
04:31 pm
maia
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
Low
Report
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
3/4
04:00 pm
maia
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
Low
Report
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
3/2
11:11 pm
maia
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock [Yahoo! Finance]
3/2
10:45 pm
maia
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Medium
Report
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
3/2
05:00 pm
maia
MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
High
Report
MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
2/24
09:18 am
maia
MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market [Yahoo! Finance]
High
Report
MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market [Yahoo! Finance]
2/24
08:45 am
maia
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
Medium
Report
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
1/20
10:15 am
maia
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
High
Report
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/4
05:20 pm
maia
Form 8-K MAIA Biotechnology, Inc. For: Mar 02
Low
Report
Form 8-K MAIA Biotechnology, Inc. For: Mar 02
3/4
09:00 am
maia
Form 424B5 MAIA Biotechnology, Inc.
Low
Report
Form 424B5 MAIA Biotechnology, Inc.
3/2
05:00 pm
maia
Form 424B5 MAIA Biotechnology, Inc.
High
Report
Form 424B5 MAIA Biotechnology, Inc.
2/24
09:01 am
maia
Form 8-K MAIA Biotechnology, Inc. For: Feb 24
High
Report
Form 8-K MAIA Biotechnology, Inc. For: Feb 24
1/20
04:31 pm
maia
Form 8-K MAIA Biotechnology, Inc. For: Jan 20
Medium
Report
Form 8-K MAIA Biotechnology, Inc. For: Jan 20
1/13
05:21 pm
maia
Form 8-K MAIA Biotechnology, Inc. For: Jan 13
Medium
Report
Form 8-K MAIA Biotechnology, Inc. For: Jan 13
1/12
08:44 am
maia
Form 4 MAIA Biotechnology, Inc. For: Sep 19 Filed by: Smith Stan
Medium
Report
Form 4 MAIA Biotechnology, Inc. For: Sep 19 Filed by: Smith Stan
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: